Viewing Study NCT01405118


Ignite Creation Date: 2025-12-25 @ 4:54 AM
Ignite Modification Date: 2026-02-22 @ 5:29 AM
Study NCT ID: NCT01405118
Status: COMPLETED
Last Update Posted: 2011-08-18
First Post: 2011-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers
Sponsor: Pfizer
Organization:

Study Overview

Official Title: A Phase 1, Open Labeled, Fixed Sequence Study To Estimate The Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers
Status: COMPLETED
Status Verified Date: 2011-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will evaluate the potential effect of CP 690,550 on the pharmacokinetics of metformin, a probe drug for organic cationic transport.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: